Investigating the potential impact of PCSK9-inhibitors on mood disorders using eQTL-based Mendelian randomization. Aman A, Slob EAW, Ward J, Cullen B, et al. PLoS One 2022;17:e0279381.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Aman A, Slob EAW, Ward J, Cullen B, et al. Investigating the potential impact of PCSK9-inhibitors on mood disorders using eQTL-based Mendelian randomization. PLoS One 2022;17:e0279381.
PMID: 36580462